FLSmidth A/S
FLSmidth & Co. A/S major shareholder announcement
FLSmidth & Co. A/S major shareholder announcement
COMPANY ANNOUNCEMENT NO. 48-2025
FLSmidth & Co. A/S
26 November 2025
Copenhagen, Denmark
In accordance with section 30 of the Danish Capital Markets Act, FLSmidth & Co. A/S (“FLSmidth” or the “Company”) hereby announces the following notification received pursuant to section 38 of the Danish Capital Markets Act from Altor Holding VI AB regarding its direct and indirect holdings and voting rights in FLSmidth.
On 25 November 2025, Altor Holding VI AB informed the Company that, as of 20 November 2025, its subsidiary, ALTOR INVEST 7 AS, holds 8,673,850 shares in FLSmidth, corresponding to 15.05% of the Company’s total share capital and voting rights (previously 14.90%).
Contacts:
Investor Relations
Andreas Holkjær, +45 24 85 03 84, andh@flsmidth.com
Jannick Denholt, +45 21 69 66 57, jli@flsmidth.com
Media
Jannick Denholt, +45 21 69 66 57, jli@flsmidth.com
About FLSmidth
FLSmidth is a full flowsheet technology and service supplier to the global mining industry. We enable our customers to improve performance, lower operating costs and reduce environmental impact. MissionZero is our sustainability ambition towards zero emissions in mining by 2030. We work within fully validated Science-Based Targets, have a clear commitment to improving the sustainability performance of the global mining industry and aim to become carbon neutral in our own operations by 2030. www.fls.com
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
ROCKWOOL A/S26.11.2025 10:47:38 CET | Press release
ROCKWOOL A/S – transactions in connection with share buy-back programme
Rockwool A/S26.11.2025 10:47:38 CET | Pressemeddelelse
ROCKWOOL A/S – transaktioner i henhold til aktietilbagekøbsprogram
Tangram Therapeutics PLC26.11.2025 10:00:00 CET | Press release
Tangram Therapeutics Submits Clinical Trial Application for Phase 1/2 Study of TGM-312, a Novel Investigational RNAi MASH Candidate
Norsk Hydro26.11.2025 10:00:00 CET | Press release
Norsk Hydro: Hydro to close five European extrusion plants
A/S Øresund26.11.2025 09:55:24 CET | Press release
3rd Quarter Results 2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom